Business Context and Reporting Period
Company: Utah Medical Products, Inc. (UTMD)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2010
Business Overview: UTMD designs, manufactures, and markets proprietary, disposable medical devices for hospital use, focusing on labor and delivery, neonatal intensive care (NICU), gynecology, and blood pressure monitoring. The company operates manufacturing facilities in Midvale, Utah, and Athlone, Ireland.
Key Financial Metrics
| Metric | 2010 | 2009 | Change |
|---|---|---|---|
| Net Sales | $25,121 | $25,916 | (3.1%) |
| Gross Profit | $13,209 | $13,789 | (4.2%) |
| Gross Margin | 52.6% | 53.2% | -0.6 pts |
| Operating Income | $8,922 | $9,432 | (5.4%) |
| Net Income | $6,014 | $6,258 | (3.9%) |
| Diluted EPS | $1.65 | $1.72 | (4.1%) |
| Operating Cash Flow | $7,157 | $7,226 | (1.0%) |
| Total Assets | $41,238 | $41,754 | (1.2%) |
| Long-term Debt | $909 | $1,403 | (35.2%) |
| Working Capital | $23,239 | $24,472 | (5.0%) |
Note: All dollar amounts in thousands except per-share data.
Material Changes vs. Prior Period
- Revenue Decline: Consolidated sales decreased by $796 (3%) primarily due to a 6% decline in domestic sales. This was driven by lower utilization rates of physician-preference devices in U.S. hospitals and a reduction in domestic OEM sales as customers reduced inventories.
- International Growth: International sales increased by 5% ($399) to $7,690, offsetting some domestic weakness. Neonatal device sales internationally grew by 31%.
- Margin Compression: Gross profit margin decreased to 52.6% from 53.2%. Factors included higher direct material costs, lower labor productivity during the consolidation of Oregon operations into Utah, and a higher fixed overhead content due to lower sales volume.
- Shareholder Returns: Despite a decline in net income, the company paid out 100% of net income in dividends ($6,030 total), including a special dividend of $0.96 per share in December 2010. Share repurchases totaled $439 for 17,570 shares.
- Debt Reduction: Long-term debt (a note payable by the Ireland subsidiary) decreased by $494 due to principal payments and favorable currency exchange effects.
Guidance, Outlook, and Risks
Management Outlook
- 2011 Revenue: Management projects overall revenues in 2011 to be approximately the same as 2010, assuming a continued small decline in domestic sales offset by international growth.
- Profitability: The company targets a net profit margin close to 24% and an operating profit margin similar to 2010 levels.
- Capital Allocation: Plans to utilize excess cash for accretive acquisitions, new technology investments, or continued dividends and share repurchases if the stock is undervalued.
Risks and Contingencies
- Regulatory Environment: Risks associated with the Patient Protection and Affordable Care Act, including a potential excise tax on medical device sales starting in 2013 and increased administrative burdens.
- Group Purchasing Organizations (GPOs): GPOs may limit market access for UTMD's specialty devices by bundling products or favoring commodity alternatives, potentially reducing revenues.
- Product Liability: The company is self-insured for product liability. While no material damages have been awarded in its history, the risk of large awards exists in the medical device sector.
- Foreign Exchange: International sales are subject to currency fluctuations. A stronger U.S. dollar in 2010 negatively impacted reported international sales.
Investor Verification Checklist
- Domestic Utilization Trends: Verify if the decline in U.S. hospital utilization of physician-preference devices (specifically Intran Plus catheters) has stabilized as management claims.
- GPO Impact: Assess the extent to which Group Purchasing Organization contracts are restricting access to new or existing UTMD products in key hospital accounts.
- International Distributor Performance: Review the concentration risk in international sales, where 10% of customers represented 80% of international revenue.
- Cost Structure: Monitor the impact of the consolidated Utah facility on long-term manufacturing overhead and labor productivity.
- Dividend Sustainability: Confirm the company's ability to maintain high dividend payouts (100% of net income in 2010) if future earnings decline or if capital is required for acquisitions.